Otezla is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis and moderate to severe plaque psoriasis in adults 18 and older. Otezla is also known by its drug name, apremilast.
Otezla is a phosphodiesterase inhibitor. Otezla is believed to work by decreasing the amount of certain molecules that cause inflammation. In people with psoriasis and psoriatic arthritis, Otezla has been shown to decrease inflammation and pain.
How do I take it?
Otezla is taken orally as a tablet twice a day.
Common side effects of Otezla include diarrhea, nausea, upper respiratory tract infection, and headache.
More serious side effects associated with Otezla include weight loss, nausea, vomiting, and depression.
For more information, visit:
Otezla — Celgene